Page last updated: 2024-10-24

carbazilquinone and Esophageal Diseases

carbazilquinone has been researched along with Esophageal Diseases in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Esophageal Diseases: Pathological processes in the ESOPHAGUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, R1
Yamazaki, Y1
Shiozaki, K1
Akai, S1
Shimada, K1
Sato, M1
Kurita, Y1
Hirono, T1
Sato, Y1

Other Studies

1 other study available for carbazilquinone and Esophageal Diseases

ArticleYear
[An operated case of the lung cancer associated with the esophageal necrosis due to the bronchial artery infusion (author's transl)].
    Kyobu geka. The Japanese journal of thoracic surgery, 1979, Volume: 32, Issue:11

    Topics: Antineoplastic Agents; Azirines; Bronchial Arteries; Carbazilquinone; Esophageal Diseases; Esophagop

1979